Novartis Ag (NVS) Common Equity (2009 - 2026)
Novartis Ag (NVS) recorded Common Equity of $41.95 billion in Q2 2026, down 0.3% from $42.05 billion a year earlier but up 7.8% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag reported Common Equity of $46.55 billion, up 5.5% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of -3.9% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $44.13 billion in FY2024 (-5.6%), $46.75 billion in FY2023 (-21.3%), $59.42 billion in FY2022 (-12.4%) and $67.82 billion in FY2021 (+19.7%).
- Quarterly Common Equity has ranged from $38.25 billion in Q3 2023 to $67.82 billion in Q4 2021 over the past five years.
- On a year-over-year basis, Common Equity rose in five of the last eight quarters, with growth averaging 1.8%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 22.0% in Q1 2022, against a decline of 37.2% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $38.93 billion (Q1 2026), $46.55 billion (Q4 2025) and $44.75 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.95 Bn |
| Mar 31, 2026 | 38.93 Bn |
| Dec 31, 2025 | 46.55 Bn |
| Sep 30, 2025 | 44.75 Bn |
| Jun 30, 2025 | 42.05 Bn |
| Mar 31, 2025 | 38.45 Bn |
| Dec 31, 2024 | 44.13 Bn |
| Sep 30, 2024 | 43.44 Bn |
| Jun 30, 2024 | 41.90 Bn |
| Mar 31, 2024 | 39.76 Bn |
| Dec 31, 2023 | 46.75 Bn |
| Sep 30, 2023 | 38.25 Bn |
| Jun 30, 2023 | 51.93 Bn |
| Mar 31, 2023 | 52.14 Bn |
| Dec 31, 2022 | 59.42 Bn |
| Sep 30, 2022 | 60.90 Bn |
| Jun 30, 2022 | 63.01 Bn |
| Mar 31, 2022 | 61.70 Bn |
| Dec 31, 2021 | 67.82 Bn |
| Sep 30, 2021 | 56.94 Bn |
API Access
Novartis Ag Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();